Sharon H Giordano

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. doi request reprint Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual?
    Fen Wei Wang
    Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA
    Catheter Cardiovasc Interv 71:636-43. 2008
  2. pmc Decline in the use of anthracyclines for breast cancer
    Sharon H Giordano
    The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA
    J Clin Oncol 30:2232-9. 2012
  3. ncbi request reprint Breast cancer treatment guidelines in older women
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 23:783-91. 2005
  4. pmc Impact of a scientific presentation on community treatment patterns for primary breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Box 424, Houston, TX 77030, USA
    J Natl Cancer Inst 98:382-8. 2006
  5. ncbi request reprint A review of the diagnosis and management of male breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 424, Houston, Texas 77030, USA
    Oncologist 10:471-9. 2005
  6. ncbi request reprint Late gastrointestinal toxicity after radiation for prostate cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:423-32. 2006
  7. pmc Risk of cardiac death after adjuvant radiotherapy for breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe, Box 424, Houston, TX 77030, USA
    J Natl Cancer Inst 97:419-24. 2005
  8. ncbi request reprint Use and outcomes of adjuvant chemotherapy in older women with breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230, USA
    J Clin Oncol 24:2750-6. 2006
  9. ncbi request reprint Breast carcinoma in men: a population-based study
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, PO Box 424, Houston, TX 77030, USA
    Cancer 101:51-7. 2004
  10. ncbi request reprint Is breast cancer survival improving?
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:44-52. 2004

Research Grants

  1. Adherence Among Older Women with Breast Cancer
    Sharon Giordano; Fiscal Year: 2007

Detail Information

Publications71

  1. doi request reprint Survival advantage in Medicare patients receiving drug-eluting stents compared with bare metal stents: real or artefactual?
    Fen Wei Wang
    Division of Cardiology, Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas, USA
    Catheter Cardiovasc Interv 71:636-43. 2008
    ..We evaluated mortality in the first year after implantation of DES, specifically the sirolimus-eluting stent (SES), Cypher vs. BMS in "real world" older patients using the Medicare claims database...
  2. pmc Decline in the use of anthracyclines for breast cancer
    Sharon H Giordano
    The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1354, Houston, TX 77030, USA
    J Clin Oncol 30:2232-9. 2012
    ..To determine the patterns of use of anthracycline- and taxane-based chemotherapy for breast cancer treatment...
  3. ncbi request reprint Breast cancer treatment guidelines in older women
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 23:783-91. 2005
    ..To determine patterns and predictors of concordance with institutional treatment guidelines among older women with breast cancer...
  4. pmc Impact of a scientific presentation on community treatment patterns for primary breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Box 424, Houston, TX 77030, USA
    J Natl Cancer Inst 98:382-8. 2006
    ....
  5. ncbi request reprint A review of the diagnosis and management of male breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Box 424, Houston, Texas 77030, USA
    Oncologist 10:471-9. 2005
    ..It shares many similarities with breast cancer in women; yet some clear differences have emerged. In this article, the latest information on the epidemiology, biology, and treatment of male breast cancer is reviewed...
  6. ncbi request reprint Late gastrointestinal toxicity after radiation for prostate cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 107:423-32. 2006
    ..The current study was designed to determine rates and predictors of late, lower gastrointestinal toxicity after radiation therapy in a population-based cohort of older men with prostate cancer...
  7. pmc Risk of cardiac death after adjuvant radiotherapy for breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe, Box 424, Houston, TX 77030, USA
    J Natl Cancer Inst 97:419-24. 2005
    ..Because radiation techniques have improved over time, we investigated whether the risk of death from ischemic heart disease after adjuvant breast radiotherapy decreased over time...
  8. ncbi request reprint Use and outcomes of adjuvant chemotherapy in older women with breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230, USA
    J Clin Oncol 24:2750-6. 2006
    ..This study was undertaken to determine patterns and outcomes of adjuvant chemotherapy use in a population-based cohort of older women with primary breast cancer...
  9. ncbi request reprint Breast carcinoma in men: a population-based study
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, PO Box 424, Houston, TX 77030, USA
    Cancer 101:51-7. 2004
    ....
  10. ncbi request reprint Is breast cancer survival improving?
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 100:44-52. 2004
    ..The objective of the current study was to determine whether the survival of women with recurrent breast cancer has improved from 1974 to 2000...
  11. ncbi request reprint Update on locally advanced breast cancer
    Sharon H Giordano
    University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Oncologist 8:521-30. 2003
    ..Inflammatory cancer is also reviewed, but is considered separately due to its distinct biology and clinical behavior...
  12. pmc Inflammatory breast cancer: clinical progress and the main problems that must be addressed
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA
    Breast Cancer Res 5:284-8. 2003
    ..This article reviews the clinical characteristics of inflammatory breast cancer and the recent advances in therapy...
  13. pmc Limits of observational data in determining outcomes from cancer therapy
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 112:2456-66. 2008
    ..Observational data are used increasingly to assess the effectiveness of therapies. However, selection biases are likely to have an impact on results and threaten the validity of these studies...
  14. doi request reprint Use of intravenous bisphosphonates in older women with breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas, Houston, Texas 77030, USA
    Oncologist 13:494-502. 2008
    ..i.v. bisphosphonates reduce skeletal events in women with bone metastases from breast cancer, but little is known about the prevalence and duration of bisphosphonate use...
  15. ncbi request reprint Adjuvant systemic therapy for male breast carcinoma
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 104:2359-64. 2005
    ..In the current study, the authors describe the M. D. Anderson experience with adjuvant systemic therapy in male breast carcinoma patients...
  16. doi request reprint Radiation use and long-term survival in breast cancer patients with T1, T2 primary tumors and one to three positive axillary lymph nodes
    Thomas A Buchholz
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 71:1022-7. 2008
    ..For patients with Stage II breast cancer with one to three positive lymph nodes, controversy exists about whether radiation as a component of treatment provides a survival benefit...
  17. doi request reprint Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes
    Shaheenah Dawood
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 27:220-6. 2009
    ..The goal of this study was to describe the effect of race on pathologic complete response (pCR) rates and survival outcomes in women with triple receptor-negative (TN) breast cancers...
  18. pmc Effectiveness of radiation for prevention of mastectomy in older breast cancer patients treated with conservative surgery
    Jeffrey M Albert
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 118:4642-51. 2012
    ..Accordingly, we used the Surveillance, Epidemiology, and End Results-Medicare observational cohort to determine the effect of RT on the risk of mastectomy among older women with stage I, ER-positive breast cancer...
  19. doi request reprint Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States
    Grace L Smith
    Department of Radiation Oncology, The Section of Health Services Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Am Coll Surg 209:425-433.e2. 2009
    ..But earlier studies report low BCS use rates of 12% to 43% nationally, especially in older patients. We sought to determine current patterns and predictors of BCS use...
  20. doi request reprint Impact of evidence-based clinical guidelines on the adoption of postmastectomy radiation in older women
    Shervin M Shirvani
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, USA
    Cancer 117:4595-605. 2011
    ..Accordingly, the authors used the Surveillance, Epidemiology, and End Results (SEER)-Medicare cohort to determine whether the use of PMRT has increased in response to evidence-based guidelines...
  21. pmc Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer
    Grace L Smith
    Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA
    JAMA 307:1827-37. 2012
    ..Because results of long-term randomized trials will not be reported for years, detailed analysis of clinical outcomes in a nonrandomized setting is warranted...
  22. doi request reprint Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation
    Grace L Smith
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
    Int J Radiat Oncol Biol Phys 88:274-84. 2014
    ..Recently proposed "suitability" criteria guiding patient selection for brachytherapy have never been empirically validated...
  23. doi request reprint Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study
    Grace L Smith
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 116:734-41. 2010
    ..Therefore, in a comprehensive, national cohort of Medicare patients, racial disparities in the use of radiotherapy (RT) after breast-conserving surgery (BCS) for invasive breast cancer were quantified...
  24. doi request reprint Risk of hypothyroidism in older breast cancer patients treated with radiation
    Grace L Smith
    Department of Breast Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 112:1371-9. 2008
    ..The authors assessed risk of hypothyroidism in breast cancer patients who were receiving RT to a supraclavicular field, which typically includes a portion of thyroid...
  25. doi request reprint Mammography capacity impact on screening rates and breast cancer stage at diagnosis
    Linda S Elting
    Section of Health Services Research, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Am J Prev Med 37:102-8. 2009
    ..S. reportedly is adequate, but has not been examined in nonmetropolitan areas. This study examined the relationships between in-county mammography facilities and rates of mammography screening and late-stage diagnosis of breast cancers...
  26. pmc Anthracycline regimen adherence in older patients with early breast cancer
    Carlos H Barcenas
    Department of Hematology and Oncology, TheUniversity of Texas MD Anderson Cancer Center, Houston, Texas, USA
    Oncologist 17:303-11. 2012
    ..Rates of anthracycline adherence in breast cancer (BC) patients are unknown, but noncompletion of chemotherapy is associated with worse outcomes...
  27. doi request reprint Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy
    Grace L Smith
    Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 26:5119-25. 2008
    ..Cerebrovascular disease is common in head and neck cancer patients, but it is unknown whether radiotherapy increases the cerebrovascular disease risk in this population...
  28. doi request reprint Adoption of intensity-modulated radiation therapy for breast cancer in the United States
    Benjamin D Smith
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1202, Houston, TX 77030, USA
    J Natl Cancer Inst 103:798-809. 2011
    ..It is thus controversial whether such treatment justifies billing for intensity-modulated radiation therapy (IMRT)...
  29. ncbi request reprint Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer
    Mary C Pinder
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:3808-15. 2007
    ..Limited data are available on long-term cardiac safety of adjuvant anthracycline chemotherapy in breast cancer patients over age 65 years. We evaluated rates and predictors of congestive heart failure (CHF) in this population...
  30. ncbi request reprint Acute myeloid leukemia after adjuvant breast cancer therapy in older women: understanding risk
    Debra A Patt
    Department of Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 25:3871-6. 2007
    ..The purpose of this study was to determine the risk of developing acute myeloid leukemia (AML) after adjuvant chemotherapy for breast cancer in older women...
  31. pmc Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review
    Shaheenah Dawood
    The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
    J Clin Oncol 28:92-8. 2010
    ..CONCLUSION Our results show that women with HER2/neu-positive disease who received trastuzumab had improved prognosis compared with women with HER2/neu-negative disease...
  32. doi request reprint Mammography before diagnosis among women age 80 years and older with breast cancer
    Brian D Badgwell
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, 1400 Holcombe Blvd, PO Box 301402, Houston, TX 77030 1402, USA
    J Clin Oncol 26:2482-8. 2008
    ..Screening mammography guidelines for patients age 80 years and older are variable. We determined the effect of mammography use on stage at breast cancer diagnosis and survival among women of this age range...
  33. pmc Patterns of treatment for early stage breast cancers at the M. D. Anderson Cancer Center from 1997 to 2004
    Yu Shen
    Department of Biostatistics, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 115:2041-51. 2009
    ..D. Anderson Cancer Center (MDACC)...
  34. ncbi request reprint Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy
    Julia L Oh
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcolmbe Blvd, Unit 1202, Houston, TX 77030, USA
    J Clin Oncol 24:4971-5. 2006
    ....
  35. ncbi request reprint Comparative analysis of sentinel lymph node operation in male and female breast cancer patients
    Judy C Boughey
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Am Coll Surg 203:475-80. 2006
    ..The purpose of this study was to determine whether SLN operation is as feasible and accurate in male patients compared with female patients...
  36. pmc Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer
    Sao Jiralerspong
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, 77030 4009, USA
    J Clin Oncol 27:3297-302. 2009
    ..Our purpose was to determine whether metformin use was associated with a change in pathologic complete response (pCR) rates in diabetic patients with breast cancer receiving neoadjuvant chemotherapy...
  37. ncbi request reprint Supraclavicular radiation for breast cancer does not increase the 10-year risk of stroke
    Wendy A Woodward
    Department of Radiation Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:2556-62. 2006
    ....
  38. pmc Pathologic complete response in breast cancer patients receiving anthracycline- and taxane-based neoadjuvant chemotherapy: evaluating the effect of race/ethnicity
    Mariana Chavez-MacGregor
    Division of Cancer Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Cancer 116:4168-77. 2010
    ..The current study was conducted to evaluate the influence of race/ethnicity and tumor subtype in pathologic complete response (pCR) following treatment with neoadjuvant chemotherapy...
  39. ncbi request reprint Cardiac morbidity of adjuvant radiotherapy for breast cancer
    Debra A Patt
    Department of Medical Oncology, Houston, TX 77030, USA
    J Clin Oncol 23:7475-82. 2005
    ..The purpose of this study was to determine whether modern adjuvant radiotherapy is associated with increased risk of cardiac morbidity...
  40. pmc A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer
    Stacy Moulder
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 118:2378-84. 2012
    ..Inhibition of mammalian target of rapamycin with everolimus may improve the efficacy of taxanes. Everolimus and docetaxel are both metabolized by CYP3A4, which could result in a pharmacokinetic (PK) interaction...
  41. pmc Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study
    Mariana Chavez-MacGregor
    Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 117:3641-9. 2011
    ..The authors evaluated the patterns of use and the risk of thromboembolic events (TEE) associated with erythropoietin-stimulating agents (ESAs) in older patients with metastatic breast cancer who were receiving chemotherapy...
  42. doi request reprint Completion of adjuvant radiation therapy among women with breast cancer
    Tomasz P Srokowski
    Department of Cancer Medicine, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 113:22-9. 2008
    ..Optimal treatment for breast cancer often involves lengthy multimodality care including 5 to 6 weeks of radiotherapy, but few studies have evaluated adherence to radiotherapy outside the context of a therapeutic clinical trial...
  43. pmc Trends in survival over the past two decades among white and black patients with newly diagnosed stage IV breast cancer
    Shaheenah Dawood
    Department of Breast Medical Oncology and Quantitative Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Clin Oncol 26:4891-8. 2008
    ..The aim of this study was to evaluate trends in and factors affecting survival in a large population-based cohort of patients with newly diagnosed stage IV breast cancer...
  44. ncbi request reprint Trends for inflammatory breast cancer: is survival improving?
    Ana M Gonzalez-Angulo
    Department of Breast Medical Oncology, Unit 1354, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030 4009, USA
    Oncologist 12:904-12. 2007
    ..Clinical trials focusing on the management of this aggressive disease are warranted. Disclosure of potential conflicts of interest is found at the end of this article...
  45. ncbi request reprint Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma
    Emer O Hanrahan
    Departments of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Unit 10, Houston, TX 77030, USA
    J Clin Oncol 25:4952-60. 2007
    ....
  46. pmc Nomogram to predict the benefit of radiation for older patients with breast cancer treated with conservative surgery
    Jeffrey M Albert
    The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 30:2837-43. 2012
    ..However, it is not known whether this recommendation should extend to other older women. Accordingly, we developed a nomogram to predict the likelihood of long-term breast preservation with and without RT...
  47. ncbi request reprint Significantly higher pathologic complete remission rate after neoadjuvant therapy with trastuzumab, paclitaxel, and epirubicin chemotherapy: results of a randomized trial in human epidermal growth factor receptor 2-positive operable breast cancer
    Aman U Buzdar
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 424, Houston, TX 77030, USA
    J Clin Oncol 23:3676-85. 2005
    ....
  48. ncbi request reprint A detailed evaluation of cardiac toxicity: a phase II study of doxorubicin and one- or three-hour-infusion paclitaxel in patients with metastatic breast cancer
    Sharon H Giordano
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 8:3360-8. 2002
    ..This Phase II study was designed to determine the efficacy and toxicity of combination doxorubicin and paclitaxel as front-line treatment for metastatic breast cancer...
  49. doi request reprint Comparative effectiveness of platinum-based chemotherapy versus taxane and other regimens for ovarian cancer
    Xianglin L Du
    Division of Epidemiology, Human Genetics, and Environmental Sciences, School of Public Health, University of Texas Health Science Center at Houston, 1200 Herman Pressler Drive, Room RAS E631, Houston, TX 77030, USA
    Med Oncol 30:440. 2013
    ..Among those with early stage tumors, platinum-taxane combination appeared more effective than other chemotherapy regimens...
  50. doi request reprint Hazard of recurrence among women after primary breast cancer treatment--a 10-year follow-up using data from SEER-Medicare
    Lee Cheng
    Department of Clinical Effectiveness, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Cancer Epidemiol Biomarkers Prev 21:800-9. 2012
    ..Few studies have used SEER-Medicare data to describe recurrence of breast cancer after primary treatment for U.S. women...
  51. pmc Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer
    Tomasz P Srokowski
    Division of Cancer Medicine, and Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    J Clin Oncol 27:2170-6. 2009
    ..To evaluate whether diabetes affects patterns of adjuvant chemotherapy use, toxic effects of chemotherapy, and breast cancer outcomes...
  52. doi request reprint Brachytherapy for accelerated partial-breast irradiation: a rapidly emerging technology in breast cancer care
    Grace L Smith
    The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 29:157-65. 2011
    ..It is currently used in the community setting, although its efficacy has yet to be validated in prospective comparative trials. Frequency and factors influencing use have not been previously identified...
  53. doi request reprint Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer
    Débora de Melo Gagliato
    All authors The University of Texas MD Anderson Cancer Center, Houston, TX
    J Clin Oncol 32:735-44. 2014
    ..We evaluated the association between TTC and survival according to breast cancer subtype and stage at diagnosis...
  54. pmc Anastrozole-associated joint pain and other symptoms in patients with breast cancer
    Qiuling Shi
    Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    J Pain 14:290-6. 2013
    ..Having AI-associated joint pain correlated with increase in or persistence of other symptoms likely related to AI therapy. Further research is needed to validate predictors of AI-associated symptoms...
  55. ncbi request reprint Efficacy of anastrozole in male breast cancer
    Sharon H Giordano
    University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Am J Clin Oncol 25:235-7. 2002
    ..D. Anderson from 1990 to 1999 were reviewed. Five male patients with metastatic breast cancer who were treated at M. D. Anderson with anastrozole were identified. We now report on these five cases...
  56. pmc Muddy water? Variation in reporting receipt of breast cancer radiation therapy by population-based tumor registries
    Gary V Walker
    Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Int J Radiat Oncol Biol Phys 86:686-93. 2013
    ..To evaluate, in the setting of breast cancer, the accuracy of registry radiation therapy (RT) coding compared with the gold standard of Medicare claims...
  57. doi request reprint Improvement in breast cancer outcomes over time: are older women missing out?
    Benjamin D Smith
    The University of Texas MD Anderson Cancer Center, Houston, USA
    J Clin Oncol 29:4647-53. 2011
    ....
  58. ncbi request reprint Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ
    Tina W F Yen
    Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    J Am Coll Surg 200:516-26. 2005
    ..The purpose of our study was to determine when the risk of finding invasive disease on final pathology in patients with an initial diagnosis of DCIS was sufficiently high to justify use of SLNB...
  59. doi request reprint Trends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United States
    Reshma Jagsi
    Reshma Jagsi and Adeyiza O Momoh, University of Michigan, Ann Arbor, MI Jing Jiang, Sharon H Giordano, Thomas A Buchholz, Steven J Kronowitz, Benjamin D Smith, The University of Texas MD Anderson Cancer Center, Houston, TX Amy Alderman, The Swan Center For Plastic Surgery, Alpharetta, GA
    J Clin Oncol 32:919-26. 2014
    ..Concerns exist regarding breast cancer patients' access to breast reconstruction, which provides important psychosocial benefits...
  60. doi request reprint The association of breast cancer and meningioma in men and women
    Ganesh Rao
    Department of Neurosurgery, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Neurosurgery 65:483-9; discussion 489. 2009
    ..An association between breast cancer and intracranial meningioma has been described in women. We sought to determine whether this connection exists in men as well, hypothesizing that causes unrelated to sex may be responsible...
  61. pmc Referral to medical oncology: a crucial step in the treatment of older patients with stage III colon cancer
    RuiLi Luo
    Sealy Center on Aging, Department of Preventive Medicine and Community Health, University of Texas Medical Branch at Galveston, Galveston, Texas, USA
    Oncologist 11:1025-33. 2006
    ..This study examines factors associated with medical oncology consultation and evaluates the impact of such consultation on chemotherapy use...
  62. ncbi request reprint Breast cancer in men
    Sharon H Giordano
    The University of Texas M D Anderson Cancer Center, Department of Breast Medical Oncology, 1515 Holcombe Boulevard, Box 424, Houston, TX 77030, USA
    Ann Intern Med 137:678-87. 2002
    ..Optimal management of breast cancer in men is unknown because the rarity of the disease precludes large randomized trials. A review of the literature was undertaken with emphasis on articles published over a 10-year period...
  63. doi request reprint Outcomes and cost of outpatient or inpatient management of 712 patients with febrile neutropenia
    Linda S Elting
    Department of Biostatistics, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd Unit 447, Houston, TX 77030, USA
    J Clin Oncol 26:606-11. 2008
    ..We retrospectively compared the outcomes and costs of outpatient and inpatient management of low-risk outpatients who presented to an emergency department with febrile neutropenia (FN)...
  64. doi request reprint Male breast cancer according to tumor subtype and race: a population-based study
    Mariana Chavez-MacGregor
    Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 119:1611-7. 2013
    ..Therefore, the objective of the current study was to explore breast tumor subtype distribution by race/ethnicity among men in the large, ethnically diverse population of California...
  65. pmc Problems in transition and quality of care: perspectives of breast cancer survivors
    Aimee Kendall Roundtree
    The University of Texas MD Anderson Cancer Center, 1400 Pressler St, Unit 1465, Houston, TX 77030, USA
    Support Care Cancer 19:1921-9. 2011
    ..We conducted a qualitative study to explore breast cancer survivors' perceptions and attitudes about their current healthcare utilization, screening, and information needs...
  66. ncbi request reprint Breast carcinoma and antihypertensive therapy
    Sharon H Giordano
    Cancer 98:1334-6. 2003
  67. ncbi request reprint Leuprolide acetate plus aromatase inhibition for male breast cancer
    Sharon H Giordano
    J Clin Oncol 24:e42-3. 2006
  68. pmc The role of the surgeon in whether patients with lymph node-positive colon cancer see a medical oncologist
    RuiLi Luo
    Department of Internal Medicine, University of Texas Medical Branch, Galveston, Texas 77555, USA
    Cancer 109:975-82. 2007
    ..Chemotherapy improves survival for patients with stage III colon cancer, but some older patients with lymph node-positive colon cancer do not see a medical oncologist and, thus, do not receive adjuvant chemotherapy...
  69. doi request reprint Time to remove the subspecialty blinders: breast cancer does not exist in isolation
    Sharon H Giordano
    J Natl Cancer Inst 100:230-1. 2008
  70. ncbi request reprint Local recurrence or cardiovascular disease: pay now or later
    Sharon H Giordano
    J Natl Cancer Inst 99:340-1. 2007
  71. ncbi request reprint Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology
    Hans Wildiers
    Department of General Medical Oncology, University Hospital Gasthuisberg, Leuven, Belgium
    Lancet Oncol 8:1101-15. 2007
    ..The available evidence was reviewed and synthesised to provide consensus recommendations regarding the care of breast cancer in older adults...

Research Grants2

  1. Adherence Among Older Women with Breast Cancer
    Sharon Giordano; Fiscal Year: 2007
    ..The proposed studies and career development activities will provide the applicant with the skills to develop into an independent investigator. ..